Officials returning from a United Nations conference were about to board a plane when federal agents seized a package they were carrying.
NYS Entity Status
NYS Filing Date
JULY 21, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - GSS UNITED LLC
AROUND THE WEB
- North Korea Accuses U.S. of ‘Mugging’ Its Diplomats in New York
By CHOE SANG-HUN - Sunday Jun 18, 2017
- Neighborhood Is Star-Spangled on Flag Day, and Every Day
By COREY KILGANNON - Tuesday Jun 13, 2017
Gerald Goldman, 94, a retired Marine who served in World War II, has made hundreds of wooden flags for friends, neighbors and local stores.
- With Health Law in Flux, Insurers Scramble to Meet Filing Deadline
By REED ABELSON - Wednesday Jun 21, 2017
Anthem, a major player in the Obamacare exchanges, announced that it would withdraw from Wisconsin and Indiana next year, along with Ohio.
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
- Shareholders Demand More Drastic Shifts at Nestlé
By STEPHANIE STROM - Tuesday Jun 27, 2017
- Rooted in Counterculture, Whole Foods’ Founder Finds an Unlikely Refuge
By MICHAEL J. de la MERCED and ALEXANDRA STEVENSON - Friday Jun 16, 2017
- Third Point, a Hedge Fund, Sets Its Activist Sights on Nestlé
By MICHAEL J. de la MERCED - Sunday Jun 25, 2017
- CRISPR Pioneer Jennifer Doudna On Gene Editing’s Potential For Good And Evil
By Noah Robischon - Tuesday Jun 20, 2017
CRISPR coinventor Jennifer Doudna talks about developing the gene-editing tool that’s poised to change the world.
Scientists now have a relatively easy and inexpensive way to read, write, and edit the building blocks of life—the genome-editing technique known as CRISPR-Cas9. And while the technology was developed only five years ago, CRISPR’s ability to target—and modify—specific sections of DNA is already supercharging the pace of scientific breakthroughs in medicine and agriculture. It’s even being used to try to bring the woolly mammoth back to life. Investors (including Bill Gates and Sean Parker) and pharmaceutical companies have plowed millions of dollars into CRISPR-driven research; philanthropies have granted millions more to support scientists working on cures for genetic diseases; and in China, at least seven human clinical trials are moving forward. But it all started when a small group of scientists, working in collaboration, stumbled on an organic biological process that had existed for millennia. Among the leaders was molecular biologist Jennifer Doudna, who heads the Doudna Lab at the University of California, Berkeley. She’s the coauthor of a new book tracing CRISPR’s evolution, A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution. “[CRISPR] is a great illustration of how technologies are born,” says Doudna. “They often come about in unexpected ways.” And the outcomes can be just as unpredictable, and dangerous—a fact that has prompted her to become a global advocate for the responsible use of CRISPR. In this excerpt, Doudna talks about its transformative power. —Noah Robischon